Nippon India Pharma Fund vs Aditya Birla Sun Life Pharma and Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8357 Cr | ₹845 Cr |
Min Investment | ₹5000 | ₹1000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 10 Jul 2019 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 31% |
Expense Ratio | 1.82 | 2.27 |
Manager | Sailesh Raj Bhan | Dhaval Joshi |
ISIN Code | INF204K01968 | INF209KB1N91 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Month | -0.49% | -1.11% |
6 Month | 11.41% | 11.56% |
1 Year | -2.1% | -3.46% |
3 Year | 23.18% | 22.56% |
5 Year | 18.41% | 15.79% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
6 Month | 2.85% | 3.66% |
1 Year | 8% | 8.33% |
3 Year | 21.14% | 20.93% |
5 Year | 18.27% | 17.28% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Year | 17.31% | 25.47% |
3 Year | 20.52% | 16.83% |
5 Year | 20.64% | 22.98% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Standard Deviation | 15.03% | 15.89% |
Sharp | 1.00% | 0.92% |
Beta | 0.91% | 0.96% |
Alpha | 0.32% | -0.92% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Dhaval Joshi |
Total AUM | ₹96086 Cr | ₹361932 Cr |
Funds Managed | 5 | 55 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 1.47 | 5 |
Large Cap | 34.68 | 25.91 |
Mid Cap | 32.06 | 41.99 |
Small Cap | 31.79 | 27.1 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 0.55 | 1.95 |
Healthcare | 99.45 | 97.23 |
Basic Materials | - | 0.82 |
Top Comparisons
HDFC Value Fund - Growth Plan
3Y Returns18.27%
HSBC Value Fund - Regular Growth
3Y Returns22.12%
ICICI Prudential Focused Equity Fund - Growth
3Y Returns22.08%
Nippon India Focused Fund - Growth Plan -Growth Option
3Y Returns13.44%
Franklin India Government Securities Fund - Growth
3Y Returns5.84%
Edelweiss Government Securities Fund - Regular Plan - Growth Option
3Y Returns6.8%
ITI ELSS Tax Saver Fund Regular - Growth
3Y Returns19.73%
NIPPON INDIA ELSS TAX SAVER FUND-Growth Plan-Growth Option
3Y Returns16.66%